Ashley Cordova

CEO · NovoCure Ltd

Rank #8,970 SEC EDGAR (United States) ↗ Files from Switzerland

Details

Officer of the companyMedical Devices & DiagnosticsNVCRSEC CIK 0001822014

Computed from SEC EDGAR filings and closing prices — not copied from any wealth ranking. Dataset . How we calculate this.

Disclosed holdings
$7.6M
1-day change
▲ 1.70%
Positions on file
1
issuers disclosed in Forms 3/4/5 and Schedules 13D/G

Disclosed holdings over time 53 weekly points

What the 1 currently disclosed position would have been worth at each week’s closing price. A rising line means the shares got more valuable, not that this person bought more.

How the line is built

Share counts are as last reported to the SEC and held constant; only prices move.

2025-09-05$4.3M – $7.6M2026-09-04

Insider activity Jun 28, 2024 – Mar 4, 2026

Ashley Cordova is recorded in filings to the U.S. SEC via EDGAR as officer of the company, and reported 15 transactions between Jun 28, 2024 and Mar 4, 2026. The buy and sell totals below count only codes P, S.

Why the other codes are excluded

Share awards (A), shares withheld to pay tax (F), option exercises (M) and gifts (G) also appear in the table, but they are consequences of a pay package or a private transfer, not a decision to buy or sell on the open market. Counting them would turn this into a compensation ranking.

Open-market buys (code P)
$996.5K
1 purchase on file priced rows only
Open-market sales (code S)
$318.0K
5 sales on file priced rows only
All reported transactions
15
every code, including awards and exercises
Pattern
Net buyer in the final 12 months of the window
last 12 months of the window

Events from filings

Detected automatically in the filings linked below. Each headline is built from the numbers in those filings, not written by a model. Newest first; events older than 45 days stay listed and are marked as older.

Ashley Cordova bought 81,550 NovoCure Ltd (NVCR) shares for $996,541 on Sep 5, 2025

Large trade for this person

Flagged because this trade was large compared with this person’s own earlier open-market trades in the same currency — not because it is large in absolute terms. A trade that is routine for one insider can be flagged for another.

Ashley Cordova bought 81,550 NovoCure Ltd (NVCR) shares for $996,541 on Sep 5, 2025
Date Insider Transaction Shares Price Value Filing
Sep 5, 2025 Ashley Cordova P Open-market purchase 81,550 held after: 437,569 $12.22 $996,541 SEC filing ↗

Source: SEC EDGAR (United States); every row links to where it was published. Event computed Sep 14, 2026.

Ashley Cordova bought 81,550 NovoCure Ltd (NVCR) shares for $996,541 on Sep 5, 2025

Unusual change in a direct holding

Flagged because the change that day in the shares this person holds directly was unusually large compared with their own earlier changes. The rows below are the open-market trades reported that day; under each share count is the balance the filing reports after that line.

Ashley Cordova bought 81,550 NovoCure Ltd (NVCR) shares for $996,541 on Sep 5, 2025
Date Insider Transaction Shares Price Value Filing
Sep 5, 2025 Ashley Cordova P Open-market purchase 81,550 held after: 437,569 $12.22 $996,541 SEC filing ↗

Source: SEC EDGAR (United States); every row links to where it was published. Event computed Sep 14, 2026.

Reported transactions

Price 0.00 is a real reported figure on gifts (G) and share awards (A) — not a missing number. The 15 most recent rows are grouped into 13 lines by date, company and transaction type — open a line to see every lot with its own source link.

How to read this list

Every row is one line of one Form 4 or Form 5, with the filing it came from. Where the record carries no price at all we leave the cell empty instead of guessing one.

The shares and money on a grouped line add up only the lots listed inside that line, and only when every one of them carries the figure. Where a group mixes more than one reporting currency we leave the money blank rather than convert — no source publishes the rate that conversion would need.

  1. NovoCure Ltd NVCR F Shares withheld for taxesnot a buy/sell decision 17,638 shares $234.6K at $13.30 SEC filing ↗
  2. NovoCure Ltd NVCR F Shares withheld for taxes × 2not a buy/sell decision 9,638 shares $131.8K
    The 2 lots that make up this line, each with the source behind it.
    Shares Price Value Filing
    7,228 $13.67 $98.8K SEC filing ↗
    2,410 $13.67 $32.9K SEC filing ↗
  3. NovoCure Ltd NVCR A Grant or awardnot a buy/sell decisionreported at zero 23,818 shares $0 at $0.00 SEC filing ↗
  4. NovoCure Ltd NVCR F Shares withheld for taxesnot a buy/sell decision 11,541 shares $158.7K at $13.75 SEC filing ↗
  5. NovoCure Ltd NVCR P Open-market purchase 81,550 shares $996.5K at $12.22 SEC filing ↗
  6. NovoCure Ltd NVCR A Grant or awardnot a buy/sell decision 833 shares $12.6K at $15.13 SEC filing ↗
  7. NovoCure Ltd NVCR A Grant or awardnot a buy/sell decision 151,181 shares $2.75M at $18.19 SEC filing ↗
  8. NovoCure Ltd NVCR S Open-market sale 2,053 shares $38.1K at $18.54 SEC filing ↗
  9. NovoCure Ltd NVCR S Open-market sale 2,341 shares $42.8K at $18.28 SEC filing ↗
  10. NovoCure Ltd NVCR S Open-market sale × 2 11,153 shares $223.3K
    The 2 lots that make up this line, each with the source behind it.
    Shares Price Value Filing
    1,808 $20.55 $37.2K SEC filing ↗
    9,345 $19.92 $186.2K SEC filing ↗
  11. NovoCure Ltd NVCR A Grant or awardnot a buy/sell decision 373 shares $5.5K at $14.75 SEC filing ↗
  12. NovoCure Ltd NVCR S Open-market sale 688 shares $13.9K at $20.14 SEC filing ↗
  13. NovoCure Ltd NVCR A Grant or awardnot a buy/sell decision 1,286 shares $15.7K at $12.24 SEC filing ↗

Disclosed holdings

Shares is the amount on the form; value is that amount times the closing price shown. Rows with no closing price are left blank, so they may add up to less than the headline figure.

What is not counted here

Each row is one filing you can open. Private companies, real estate, bonds and crypto are not in SEC insider filings and are therefore not counted here.

Equity positions disclosed to the SEC, with the source filing behind each row.
Issuer Ticker Security Shares Close Value Form Reported Filing
NovoCure Ltd NVCR Ordinary Shares 422,570 $17.94 $7.6M 4 EDGAR ↗

Other insiders at the same companies

People who also file with the SEC at a company where Ashley Cordova reports shares.

Sharing a filing does not mean they work together day to day — it means both names appear on the same issuer’s insider record.

Sources

The filings linked in the tables above are the sources for every figure on this page.

Think a number here is wrong? Open the linked filing and compare — how to report it.

Profile record last refreshed Sep 8, 2026.